Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression

Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 14 months after initial diagnosis. Novel therapeutic approaches are an unmet need for GBM treatment. MicroRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozada-Delgado, Eunice L., Grafals-Ruiz, Nilmary, Miranda-Román, Miguel A., Santana-Rivera, Yasmarie, Valiyeva, Fatma, Rivera-Díaz, Mónica, Marcos-Martínez, María J., Vivas-Mejía, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210372/
https://www.ncbi.nlm.nih.gov/pubmed/30322013
http://dx.doi.org/10.3390/cancers10100382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210372/
https://www.ncbi.nlm.nih.gov/pubmed/30322013
http://dx.doi.org/10.3390/cancers10100382

Ejemplares similares